Is It Too Late to Buy Moderna Stock?
12/12 12:00
Moderna (NASDAQ: MRNA) stock already brought investors a 434% gain last year -- and it's heading for a 160% increase in 2021. That's after the biotech company became the second to commercialize a coronavirus vaccine -- and claimed the title of market leader along with Pfizer. Mod...